028300.KQ
Get informed when a big investor buys or sells
+ FollowOvervalued by 181.8% based on the discounted cash flow analysis.
| Market cap | $6.07 Trillion |
|---|---|
| Enterprise Value | $6.34 Trillion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1680.07 |
| Beta | 0.55 |
| Outstanding Shares | 132,903,000 |
| P/E Ratio | -28.27 |
|---|---|
| PEG | -84.75 |
| Price to Sales | 58.66 |
| Price to Book Ratio | 13.53 |
| Enterprise Value to Revenue | 65.01 |
| Enterprise Value to EBIT | -64.89 |
| Enterprise Value to Net Income | -30 |
| Total Debt to Enterprise | 0.05 |
| Debt to Equity | 0.86 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
No data
HLB Co., Ltd. operates in two distinct sectors: pharmaceutical production and naval construction. In South Korea, its maritime division produces and distributes a diverse range of lifeboats, catering to offshore platforms, drilling vesse...